SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-24-137433
Filing Date
2024-05-13
Accepted
2024-05-13 19:21:56
Documents
1
Group Members
CRG PARTNERS III (CAYMAN) LEV AIV I L.PCRG PARTNERS III (CAYMAN) UNLEV AIV I L.PCRG PARTNERS III L.PCRG PARTNERS III PARALLEL FUND A L.PCRG PARTNERS III PARALLEL FUND B (CAYMAN) L.PNATHAN D. HUKILL

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d838783dsc13da.htm SC 13D/A 127975
  Complete submission text file 0001193125-24-137433.txt   129921
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Subject) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88541 | Film No.: 24940976
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1000 MAIN STREET, SUITE 2500 HOUSTON TX 77002
Business Address 1000 MAIN STREET, SUITE 2500 HOUSTON TX 77002 713-209-7350
CR Group L.P. (Filed by) CIK: 0001702352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A